Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saeed Hamid

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission updateGraham S Cooke, Barnaby Flower, Evan Cunningham, et al.
Hepatology International|December 26, 2022
AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational studyRakhi Maiwall, Samba Siva Rao Pasupuleti, Ashok Choudhury, et al.
Hepatology International|July 24, 2015
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014Shiv Kumar Sarin, Chandan Kumar Kedarisetty, Zaigham Abbas, et al.
Journal of Viral Hepatitis|August 25, 2018
Findings from a large Asian chronic hepatitis C real-life studySeng Gee Lim, Wah Wah Phyo, Samir R Shah, et al.
Hepatology International|July 19, 2022
Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC)Sanchit Sharma, Samagra Agarwal, Anoop Saraya, et al.
Signal Transduction and Targeted Therapy|January 30, 2023
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trialHuijie Bian, Liang Chen, Zhao-Hui Zheng, et al.
The Lancet. Microbe|April 12, 2025
Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the fieldSheila F Lumley, Jolynne Mokaya, Tongai G Maponga, et al.
Hepatology International|February 15, 2023
Identifying the early predictors of non-response to steroids in patients with flare of autoimmune hepatitis causing acute-on-chronic liver failureSanchit Sharma, Samagra Agarwal, Anoop Saraya, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2025
Global Burden of Major Chronic Liver Diseases in 2021Gong Feng, Yusuf Yilmaz, Luca Valenti, et al.
NEJM Evidence|February 6, 2024
Four-Month High-Dose Rifampicin Regimens for Pulmonary TuberculosisAmina Jindani, Daniel Atwine, Daniel Grint, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission updateGraham S Cooke, Barnaby Flower, Evan Cunningham, et al.
Hepatology International|December 26, 2022
AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational studyRakhi Maiwall, Samba Siva Rao Pasupuleti, Ashok Choudhury, et al.
Hepatology International|July 24, 2015
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014Shiv Kumar Sarin, Chandan Kumar Kedarisetty, Zaigham Abbas, et al.
Journal of Viral Hepatitis|August 25, 2018
Findings from a large Asian chronic hepatitis C real-life studySeng Gee Lim, Wah Wah Phyo, Samir R Shah, et al.
Hepatology International|July 19, 2022
Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC)Sanchit Sharma, Samagra Agarwal, Anoop Saraya, et al.
Signal Transduction and Targeted Therapy|January 30, 2023
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trialHuijie Bian, Liang Chen, Zhao-Hui Zheng, et al.
The Lancet. Microbe|April 12, 2025
Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the fieldSheila F Lumley, Jolynne Mokaya, Tongai G Maponga, et al.
Hepatology International|February 15, 2023
Identifying the early predictors of non-response to steroids in patients with flare of autoimmune hepatitis causing acute-on-chronic liver failureSanchit Sharma, Samagra Agarwal, Anoop Saraya, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2025
Global Burden of Major Chronic Liver Diseases in 2021Gong Feng, Yusuf Yilmaz, Luca Valenti, et al.
NEJM Evidence|February 6, 2024
Four-Month High-Dose Rifampicin Regimens for Pulmonary TuberculosisAmina Jindani, Daniel Atwine, Daniel Grint, et al.
Pageof 16